{"gene":"SCO2","run_date":"2026-06-10T07:46:29","timeline":{"discoveries":[{"year":1999,"finding":"Mutations in human SCO2 cause fatal infantile cardioencephalomyopathy with COX deficiency; immunohistochemical studies showed the enzymatic deficiency was due to loss of mtDNA-encoded COX subunits (COX I–III), most severely in cardiac and skeletal muscle, establishing SCO2 as a COX assembly factor.","method":"Patient mutation identification, immunohistochemistry of COX subunits in patient tissues","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — foundational disease-gene paper with multiple patients, direct immunohistochemical localization of defect, independently replicated in many subsequent studies","pmids":["10545952"],"is_preprint":false},{"year":1996,"finding":"Yeast SCO2 (Sco2p) is a mitochondrial membrane-localized protein that, when overexpressed, can partially suppress respiratory defects caused by absence of the copper recruitment factor Cox17p, but cannot suppress loss of Sco1p, indicating Sco1p and Sco2p have overlapping but non-identical functions in mitochondrial copper delivery to cytochrome oxidase.","method":"Multicopy suppressor screen in Saccharomyces cerevisiae, respiratory growth assays, genetic epistasis with cox17 and sco1 null mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple mutant combinations, replicated conceptually across many subsequent studies","pmids":["8702795"],"is_preprint":false},{"year":2004,"finding":"Human SCO1 and SCO2 have non-overlapping, cooperative functions in mitochondrial copper delivery to COX. Overexpression of COX17 rescued COX deficiency in SCO2 but not SCO1 patient cells. Overexpression of either SCO protein in the reciprocal patient background produced a dominant-negative phenotype, suggesting physical interaction. Size exclusion chromatography indicated both proteins function as homodimers. A model was proposed in which COX17 delivers copper to SCO2, which transfers it to the CuA site, a reaction facilitated by SCO1.","method":"Immunoblot analysis, overexpression rescue experiments in patient cell lines, chimeric protein complementation, size exclusion chromatography","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (rescue, dominant-negative, chromatography) in a single rigorous study with patient cell lines","pmids":["15229189"],"is_preprint":false},{"year":2005,"finding":"Human Sco1 and Sco2 bind copper ions; both can bind Cu(I) (trigonal geometry) and Cu(II) (type II site). The two conserved cysteines and a histidyl residue critical for copper binding in yeast Sco1 are also critical for in vivo function of human Sco1 and Sco2. Asp238 in human Sco1 (conserved in yeast) is required for Cu(II) binding and normal function; its mutation abrogates the Cu(II) visible transitions and renders the protein nonfunctional.","method":"Expression of soluble domains in bacteria and yeast cytoplasm, X-ray absorption spectroscopy (EXAFS/XANES), site-directed mutagenesis, in vivo yeast complementation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro copper-binding characterization combined with mutagenesis and in vivo functional assays, multiple orthogonal spectroscopic methods","pmids":["16091356"],"is_preprint":false},{"year":2007,"finding":"Human SCO1 and SCO2 have additional roles in cellular copper homeostasis beyond COX assembly. Mutations in either SCO cause cellular copper deficiency that is tissue- and allele-specific and dissociable from COX assembly defects. This phenotype reflects increased copper efflux rather than reduced uptake, and can be suppressed by overexpression of SCO2 but not SCO1, suggesting a mitochondrial pathway for regulating cellular copper content that signals through SCO1 and SCO2.","method":"Patient cell line analysis, shRNA knockdown, copper efflux/uptake measurements, overexpression rescue experiments","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (RNAi, overexpression, copper flux assays) in patient and control cells, single lab","pmids":["17189203"],"is_preprint":false},{"year":2007,"finding":"NMR structure of the soluble domain of human Sco2 was determined in apo and Cu(I)-loaded forms. The structural and metal-binding features of Cu(I)Sco2 are similar to Sco1, but the dynamic properties and conformational disorder of the apo forms differ substantially between Sco1 and Sco2, accounting for their different physicochemical properties. Known pathogenic mutations were mapped onto this structure.","method":"NMR spectroscopy (structure determination and dynamics), copper(I) binding characterization","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — atomic resolution NMR structure with functional (dynamics) validation, single lab","pmids":["17850752"],"is_preprint":false},{"year":2009,"finding":"SCO2 acts upstream of SCO1 in COX II (CO II) biogenesis and is indispensable for CO II synthesis. Pulse-labeling showed CO II synthesis is reduced in SCO2, but not SCO1, patient cells. SCO2 also acts as a thiol-disulphide oxidoreductase to oxidize the copper-coordinating cysteines in SCO1 during CO II maturation; perturbation of the ratio of oxidized to reduced cysteines in SCO1 occurs in both SCO backgrounds and is corrected by SCO2 modulation.","method":"Mitochondrial translation pulse-labeling, RNAi knockdown, thiol-trapping/redox state analysis of SCO1 cysteines, patient cell lines","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (pulse-labeling, RNAi, redox state assay) establishing epistatic order and enzymatic function, replicated conceptually across labs","pmids":["19336478"],"is_preprint":false},{"year":2000,"finding":"In a yeast model, the S240F mutation in Sco1p (corresponding to a human SCO2 pathogenic mutation) allows partial but incorrect assembly of cytochrome oxidase with altered cytochrome aa3 spectrum and a specific absence of subunit 2 from the assembled complex, indicating Sco1p (and by orthology SCO2) provides copper to the CuA site on subunit 2 at a late step in the assembly pathway.","method":"Yeast site-directed mutagenesis, respiratory growth assays, spectrophotometric cytochrome analysis, immunoblot of COX subunits","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean yeast model with mutagenesis and biochemical characterization, ortholog study rather than direct human SCO2 experiment","pmids":["10854440"],"is_preprint":false},{"year":2001,"finding":"Recombinant human Sco2 protein binds copper with 1:1 stoichiometry and forms homomeric complexes in vitro independent of the CxxxC metal-binding motif. In patient myoblasts, COX activity was completely rescued by retroviral SCO2 gene transduction, and also by copper-histidine supplementation (300 µM) to culture medium, establishing that exogenous copper can bypass Sco2 function.","method":"Recombinant protein production and copper-binding assay, retroviral gene complementation in patient myoblasts, copper supplementation rescue assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro copper binding plus cell-based complementation, single lab","pmids":["11751685"],"is_preprint":false},{"year":2002,"finding":"COX deficiency in SCO2-mutant fibroblasts, myoblasts, and myotubes can be restored to near-normal levels by addition of CuCl2 to culture medium, confirming that the primary defect is in copper delivery to COX.","method":"Copper supplementation in cultured patient cells, spectrophotometric COX activity assay","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell types tested, consistent with copper-delivery function, single lab","pmids":["11931660"],"is_preprint":false},{"year":2004,"finding":"Mutant Sco2 proteins (E140K and S225F) differ from wild-type in physical conformation (circular dichroism, thermal denaturation) and copper-binding capacity: E140K binds markedly less copper and forms a non-reducible dimer (vs. monomer for wild-type), while S225F binds more copper than wild-type. These data show pathogenic mutations alter protein conformation and disrupt normal copper transport.","method":"Recombinant protein production, circular dichroism spectroscopy, thermal denaturation, copper-binding assays, gel electrophoresis","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical and biophysical characterization with multiple methods, single lab","pmids":["14972329"],"is_preprint":false},{"year":2005,"finding":"In SCO2 patient tissues (heart, skeletal muscle, brain), COX assembly intermediates accumulate including a COX1·COX4·COX5A subcomplex and free COX4·COX5A subcomplex, with virtual absence of free COX2, indicating that absence of the CuA centre reduces COX2 stability and that association of COX4 and COX5A precedes their addition to COX1. Liver in SCO2 patients contained normal holoenzyme levels despite reduced SCO2 protein.","method":"Blue native PAGE of patient tissues, immunoblot of COX subunits and subcomplexes, analysis across multiple tissues","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct analysis of assembly intermediates in multiple patient tissues, defines pathway order, single lab","pmids":["16083427"],"is_preprint":false},{"year":2010,"finding":"SCO2 is required for COX assembly in vivo; homozygous Sco2 knockout mice are embryonic lethal. Compound heterozygous knock-in/knockout mice (KI/KO, expressing E129K corresponding to human E140K) are viable but show muscle weakness, respiratory chain deficiencies, COX assembly defects, and reduced mitochondrial copper content in multiple tissues, without reduction in total tissue copper.","method":"Mouse knockout and knock-in model generation, respiratory chain enzyme assays, COX assembly analysis, copper content measurement (ICP-MS)","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic mouse model with multiple biochemical readouts, establishes essential function in vivo","pmids":["19837698"],"is_preprint":false},{"year":2011,"finding":"Using the mitochondria-targeted copper sensor Mito-CS1, total copper and exchangeable mitochondrial Cu(+) pools in SCO1 and SCO2 patient fibroblasts are largely unaltered relative to wild-type controls despite global cellular copper deficiency, demonstrating that cells prioritize mitochondrial copper homeostasis even when SCO metallochaperones are defective.","method":"Targetable fluorescent copper sensor (Mito-CS1) live-cell imaging, biochemical copper measurements in patient fibroblasts","journal":"Journal of the American Chemical Society","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — novel chemical tool with biochemical validation, single lab, patient fibroblasts","pmids":["21563821"],"is_preprint":false},{"year":2010,"finding":"SCO1 localizes predominantly to blood vessels (endothelium) in mouse and human tissues, whereas SCO2 is barely detectable in this tissue; conversely, SCO1 expression is very high in liver while SCO2 is high in muscle. This differential tissue distribution provides a mechanistic basis for the distinct tissue-specific COX deficiencies and different clinical phenotypes associated with SCO1 vs. SCO2 mutations.","method":"Immunofluorescence and immunohistochemistry of mouse and human tissue sections, tissue fractionation","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by IHC/IF across multiple tissues in two species, functional inference drawn from differential expression patterns","pmids":["20864674"],"is_preprint":false},{"year":2014,"finding":"COX20 acts as an early chaperone that stabilizes newly synthesized COX2 and presents it to the SCO1/SCO2 metallochaperone module. Immunoprecipitation showed COX20 interacts with newly synthesized COX2, and SCO1 and SCO2 act on COX20-bound COX2. Loss of COX20 generates COX1·COX4-containing subassemblies similar to those in SCO1/SCO2 patient fibroblasts, establishing the pathway order: COX20 → COX2 stabilization → SCO1/SCO2 maturation.","method":"siRNA knockdown, TALEN knockout cell lines, mitochondrial translation pulse-labeling, co-immunoprecipitation with COX20-FLAG, blue native PAGE","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal genetic and biochemical approaches, co-IP establishes physical interaction, pathway order confirmed by matching assembly intermediates","pmids":["24403053"],"is_preprint":false},{"year":2015,"finding":"COA6 interacts transiently with the copper-containing catalytic domain of newly synthesized COX2, and COA6 and SCO2 physically interact; pathogenic mutations in either protein disrupt the COA6-SCO2 complex. Genetic epistasis in yeast showed that simultaneous deletion of Coa6 and Sco2 completely abrogates Cox2 biogenesis, and overexpression of Sco proteins partially rescues the coa6Δ phenotype, placing COA6 in the SCO2-containing copper relay system for COX2 metallation.","method":"Co-immunoprecipitation, pulse-labeling, yeast genetic epistasis (double deletion), overexpression rescue, biochemical interaction studies","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, genetic epistasis across species, pulse-labeling, multiple orthogonal methods","pmids":["25959673"],"is_preprint":false},{"year":2015,"finding":"In yeast, simultaneous deletion of Coa6 and Sco2 completely abrogates Cox2 biogenesis, and copper supplementation fails to rescue Cox2 levels in these double mutants (unlike coa6Δ single mutants). Physical interactions between Coa6, Cox2, Cox12, and Sco proteins were demonstrated biochemically, placing COA6/SCO2 in the same copper delivery pathway to Cox2.","method":"Yeast genetic epistasis (comprehensive double deletions), biochemical co-precipitation, western blot, copper supplementation rescue assays","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — comprehensive epistasis plus physical interaction studies, independent corroboration of COA6-SCO2 pathway from two labs (PMID 25959673 and 26669719)","pmids":["26669719"],"is_preprint":false},{"year":2013,"finding":"SCO2 induces apoptosis by increasing ROS generation, which causes dissociation of the ASK-1/thioredoxin (Trx) inhibitory complex and phosphorylation of ASK-1 at Thr845, activating downstream JNK/p38 apoptotic cascades in tumor xenografts. This establishes an apoptotic function for SCO2 via the ROS-ASK-1 kinase pathway downstream of p53.","method":"Tumor xenograft model, ROS measurement, co-immunoprecipitation (ASK-1/Trx), kinase phosphorylation assays, exogenous SCO2 gene addition","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical assays and in vivo xenograft validation, single lab","pmids":["23319048"],"is_preprint":false},{"year":2010,"finding":"Recombinant full-length TAT-L-Sco2 fusion protein can be transduced into mitochondria of human cell lines and processed to the mature Sco2 protein; transduction into SCO2/COX-deficient patient fibroblasts led to partial recovery of COX activity, demonstrating that exogenous delivery of functional Sco2 protein to mitochondria is sufficient to restore enzymatic activity.","method":"Protein transduction domain (PTD/TAT) technology, subcellular fractionation, cell-free translation/import assay with 35S-labeling, COX activity assay in patient fibroblasts","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct mitochondrial import demonstrated by radiolabeling and fractionation, functional rescue in patient cells, single lab","pmids":["20193760"],"is_preprint":false},{"year":2018,"finding":"SCO2 patient fibroblasts with compound heterozygous mutations near the conserved CxxxC copper-binding motif show reduced SCO2 protein levels, decreased cellular copper levels, and COX deficiency, establishing that SCO2 mutations cause cellular copper deficiency as part of the pathogenic mechanism in axonal Charcot-Marie-Tooth disease.","method":"Patient fibroblast analysis, immunoblot, copper content measurement, COX activity assay","journal":"Brain : a journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient cell biochemical analysis, single lab, extends copper-deficiency mechanism to a new disease context","pmids":["29351582"],"is_preprint":false},{"year":2000,"finding":"COX deficiency in SCO2 patient fibroblasts can be rescued by transfer of chromosome 22 (which carries SCO2) but not other chromosomes, confirming SCO2 is the causative gene. The COX deficiency (~50%) in patient fibroblasts did not result in a decrease in steady-state levels of COX subunit polypeptides, suggesting a functional rather than structural assembly defect.","method":"Chromosome transfer rescue experiment (microcell-mediated chromosome transfer), COX enzyme activity assay, immunoblot of COX subunits","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chromosome transfer rescue establishes causality, single lab","pmids":["10749987"],"is_preprint":false}],"current_model":"SCO2 is a mitochondrial inner membrane metallochaperone that functions in two key roles: (1) it acts upstream of SCO1 in COX2 (COXII) biogenesis by being required for COX2 synthesis and by acting as a thiol-disulfide oxidoreductase that oxidizes the copper-coordinating cysteines in SCO1, enabling CuA site maturation of COX2 within a COX20→COX2→(SCO2/SCO1) assembly pathway that also involves COA6; and (2) together with SCO1, it participates in a mitochondrial signaling pathway that regulates cellular copper homeostasis by controlling copper efflux, explaining tissue-specific COX deficiencies and broader copper metabolism phenotypes caused by SCO2 mutations."},"narrative":{"mechanistic_narrative":"SCO2 is a mitochondrial copper metallochaperone required for the biogenesis of cytochrome c oxidase (COX), where its loss produces severe, tissue-specific COX deficiency underlying fatal infantile cardioencephalomyopathy [PMID:10545952, PMID:10749987]. SCO2 binds copper in both Cu(I) and Cu(II) states through conserved CxxxC cysteines and a critical histidine, and adopts a thioredoxin-like fold whose apo-form dynamics distinguish it from its paralog SCO1 [PMID:16091356, PMID:17850752]. Within COX2 maturation, SCO2 acts upstream of SCO1: it is indispensable for COX2 synthesis and functions as a thiol-disulfide oxidoreductase that oxidizes the copper-coordinating cysteines of SCO1, enabling delivery of copper to the CuA site of COX2 [PMID:19336478, PMID:10854440]. This metallation occurs within an ordered assembly pathway in which COX20 stabilizes newly synthesized COX2 and presents it to the SCO1/SCO2 module, with COA6 acting in the same copper relay and physically engaging SCO2 [PMID:24403053, PMID:25959673, PMID:26669719]; loss of the CuA centre destabilizes COX2 and arrests assembly at COX1-COX4-COX5A subcomplexes [PMID:16083427]. SCO2 also participates with SCO1 in a mitochondrial signaling pathway that governs whole-cell copper homeostasis by controlling copper efflux, such that SCO2 mutations cause dissociable cellular copper deficiency distinct from the COX defect [PMID:17189203]. Consistent with a copper-delivery function, COX activity in SCO2-mutant patient cells is restored by copper supplementation [PMID:11931660], and SCO2 is essential in vivo, with knockout embryonic lethality and copper-dependent respiratory phenotypes in mouse models [PMID:19837698]. Beyond COX assembly, SCO2 has been linked to a p53-downstream apoptotic function via ROS-mediated ASK-1 activation [PMID:23319048] and to axonal Charcot-Marie-Tooth disease through copper-deficiency mechanisms [PMID:29351582].","teleology":[{"year":1996,"claim":"Established that the SCO gene products act in mitochondrial copper delivery to cytochrome oxidase, distinguishing SCO2 from the related copper factors SCO1 and COX17.","evidence":"Multicopy suppressor screen and genetic epistasis with cox17 and sco1 nulls in yeast","pmids":["8702795"],"confidence":"High","gaps":["Did not define the human SCO2 biochemical activity","Overlapping vs. distinct roles of Sco1p and Sco2p left unresolved"]},{"year":1999,"claim":"Identified SCO2 as a human disease gene and a COX assembly factor, explaining a fatal infantile cardioencephalomyopathy through loss of mtDNA-encoded COX subunits.","evidence":"Patient mutation identification and immunohistochemistry of COX subunits in patient tissues","pmids":["10545952"],"confidence":"High","gaps":["Molecular function of SCO2 in assembly not yet defined","Basis of tissue specificity unknown"]},{"year":2000,"claim":"Confirmed SCO2 causality by complementation and showed the defect is functional rather than structural, while ortholog modeling placed Sco activity at a late CuA-metallation step on COX2.","evidence":"Microcell-mediated chromosome 22 transfer rescue in patient fibroblasts; yeast S240F mutagenesis with spectrophotometric COX analysis","pmids":["10749987","10854440"],"confidence":"Medium","gaps":["Direct human SCO2 enzymatic role not yet shown","How copper reaches CuA mechanistically unresolved"]},{"year":2001,"claim":"Demonstrated that recombinant human Sco2 binds copper and that exogenous copper or SCO2 gene transfer rescues COX in patient cells, framing SCO2 as a copper-delivery protein.","evidence":"Recombinant copper-binding assay, retroviral complementation and copper-histidine supplementation in patient myoblasts","pmids":["11751685"],"confidence":"Medium","gaps":["Stoichiometry and copper-binding site not yet structurally defined","Single-lab cell-based rescue"]},{"year":2002,"claim":"Generalized the copper-delivery defect across multiple SCO2-mutant cell types by showing CuCl2 rescues COX activity.","evidence":"Copper supplementation and spectrophotometric COX assays in patient fibroblasts, myoblasts, myotubes","pmids":["11931660"],"confidence":"Medium","gaps":["Did not separate intramitochondrial from systemic copper effects","Single lab"]},{"year":2004,"claim":"Showed SCO1 and SCO2 have non-overlapping cooperative roles and likely interact physically, and that pathogenic mutations alter conformation and copper binding.","evidence":"Overexpression rescue and dominant-negative complementation in patient cells, size-exclusion chromatography; recombinant CD/thermal denaturation and copper-binding of E140K and S225F mutants","pmids":["15229189","14972329"],"confidence":"High","gaps":["Direct physical SCO1-SCO2 interaction inferred, not co-purified","Mechanism of dominant-negative effect unresolved"]},{"year":2005,"claim":"Defined the copper-binding chemistry and the residues essential for SCO function, and resolved the COX2 assembly intermediates that accumulate without the CuA centre.","evidence":"EXAFS/XANES and site-directed mutagenesis with yeast complementation; blue native PAGE of patient tissues","pmids":["16091356","16083427"],"confidence":"High","gaps":["Catalytic mechanism of copper transfer not yet defined","Basis for liver sparing unexplained"]},{"year":2007,"claim":"Revealed a COX-independent role for SCO2 in cellular copper homeostasis acting through control of copper efflux, and that SCO2 (not SCO1) overexpression suppresses the copper-deficiency phenotype.","evidence":"Patient cells, shRNA knockdown, copper efflux/uptake assays and overexpression rescue; NMR structure of Cu(I)/apo Sco2 soluble domain","pmids":["17189203","17850752"],"confidence":"High","gaps":["Signaling intermediates linking mitochondrial SCO status to efflux unknown","Structural difference vs. SCO1 not linked to distinct catalysis"]},{"year":2009,"claim":"Established the epistatic order and enzymatic activity: SCO2 acts upstream of SCO1 and oxidizes SCO1's copper-coordinating cysteines as a thiol-disulfide oxidoreductase during COX2 maturation.","evidence":"Mitochondrial translation pulse-labeling, RNAi, and thiol-trapping redox-state analysis in patient cells","pmids":["19336478"],"confidence":"High","gaps":["Direct redox enzymology not reconstituted in vitro","Source of oxidizing equivalents for SCO2 unknown"]},{"year":2010,"claim":"Demonstrated SCO2 is essential in vivo and that tissue-specific paralog expression and exogenous protein delivery account for and can correct the disease phenotype.","evidence":"Sco2 knockout/knock-in mouse models with ICP-MS copper measurement; IHC/IF tissue distribution of SCO1 vs SCO2; TAT-Sco2 protein transduction into patient fibroblasts","pmids":["19837698","20864674","20193760"],"confidence":"High","gaps":["Mechanism of mitochondrial copper reduction without total tissue copper change unresolved","Therapeutic transduction only partially restored activity"]},{"year":2011,"claim":"Showed cells prioritize mitochondrial copper pools even when SCO chaperones are defective, refining where the copper-homeostasis defect manifests.","evidence":"Mito-CS1 fluorescent copper sensor imaging and biochemical copper measurement in patient fibroblasts","pmids":["21563821"],"confidence":"Medium","gaps":["Cytosolic copper-deficiency mechanism not directly imaged","Single lab, single tool"]},{"year":2013,"claim":"Identified a non-assembly, p53-downstream apoptotic role for SCO2 via ROS-driven ASK-1 activation.","evidence":"Tumor xenografts, ROS measurement, ASK-1/Trx co-IP and kinase phosphorylation assays with exogenous SCO2","pmids":["23319048"],"confidence":"Medium","gaps":["Link between SCO2 copper/COX function and ROS generation not mechanistically connected","Single-lab finding in tumor context"]},{"year":2014,"claim":"Placed SCO2 within an ordered assembly line by identifying COX20 as the upstream chaperone that stabilizes COX2 and presents it to the SCO1/SCO2 module.","evidence":"siRNA/TALEN knockout, pulse-labeling, COX20-FLAG co-IP and blue native PAGE","pmids":["24403053"],"confidence":"High","gaps":["Direct handoff mechanism from COX20 to SCO2 not resolved","Whether SCO2 binds COX20-COX2 directly not shown"]},{"year":2015,"claim":"Integrated COA6 into the SCO2 copper relay through physical interaction and cross-species epistasis, defining a metallation module for COX2.","evidence":"Reciprocal co-IP, pulse-labeling, yeast double-deletion epistasis and copper-supplementation rescue across two independent studies","pmids":["25959673","26669719"],"confidence":"High","gaps":["Order of copper transfer among COA6, SCO2, SCO1 not fully resolved","Whether COA6 is a copper carrier or stabilizer undetermined"]},{"year":2018,"claim":"Extended the SCO2 copper-deficiency mechanism to a new disease, axonal Charcot-Marie-Tooth disease, linking CxxxC-proximal mutations to reduced cellular copper and COX deficiency.","evidence":"Patient fibroblast immunoblot, copper content and COX activity assays","pmids":["29351582"],"confidence":"Medium","gaps":["Neuron-specific pathogenic mechanism not directly tested","Single-lab patient analysis"]},{"year":null,"claim":"How the mitochondrial SCO1/SCO2 status is transduced into a cytosolic copper-efflux signal, and how SCO2's redox/copper-transfer chemistry is reconstituted in vitro, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No identified signaling intermediate linking SCO status to copper exporters","No in vitro reconstitution of SCO2-catalyzed CuA metallation","Mechanistic link between SCO2 and ROS/apoptosis pathway unestablished"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[6]},{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[6]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[3,5,8]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[1,12,19]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,6,15]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[4,7]}],"complexes":[],"partners":["SCO1","COX20","COA6","COX2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O43819","full_name":"Cytochrome c oxidase assembly factor SCO2","aliases":[],"length_aa":266,"mass_kda":29.8,"function":"Copper metallochaperone essential for the synthesis and maturation of cytochrome c oxidase subunit II (MT-CO2/COX2); together with SCO1, facilitates the incorporation of copper into the Cu(A) site of MT-CO2/COX2 (PubMed:15229189, PubMed:17189203, PubMed:19336478, PubMed:35750769). Could also act as a thiol-disulfide oxidoreductase to regulate the redox state of the cysteines in SCO1 during maturation of MT-CO2/COX2 (PubMed:19336478)","subcellular_location":"Mitochondrion inner membrane","url":"https://www.uniprot.org/uniprotkb/O43819/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SCO2","classification":"Not Classified","n_dependent_lines":145,"n_total_lines":1208,"dependency_fraction":0.12003311258278146},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SCO2","total_profiled":1310},"omim":[{"mim_id":"618064","title":"CYTOCHROME c OXIDASE ASSEMBLY FACTOR 16; COX16","url":"https://www.omim.org/entry/618064"},{"mim_id":"615431","title":"MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23","url":"https://www.omim.org/entry/615431"},{"mim_id":"614772","title":"CYTOCHROME c OXIDASE ASSEMBLY FACTOR 6; COA6","url":"https://www.omim.org/entry/614772"},{"mim_id":"614698","title":"CYTOCHROME c OXIDASE ASSEMBLY FACTOR COX20; COX20","url":"https://www.omim.org/entry/614698"},{"mim_id":"608908","title":"MYOPIA 6; MYP6","url":"https://www.omim.org/entry/608908"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SCO2"},"hgnc":{"alias_symbol":["SCO1L"],"prev_symbol":["MYP6"]},"alphafold":{"accession":"O43819","domains":[{"cath_id":"3.40.30.10","chopping":"106-261","consensus_level":"high","plddt":95.8413,"start":106,"end":261},{"cath_id":"1.20.5","chopping":"61-98","consensus_level":"medium","plddt":89.9492,"start":61,"end":98}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43819","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43819-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43819-F1-predicted_aligned_error_v6.png","plddt_mean":83.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SCO2","jax_strain_url":"https://www.jax.org/strain/search?query=SCO2"},"sequence":{"accession":"O43819","fasta_url":"https://rest.uniprot.org/uniprotkb/O43819.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43819/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43819"}},"corpus_meta":[{"pmid":"10545952","id":"PMC_10545952","title":"Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10545952","citation_count":455,"is_preprint":false},{"pmid":"8702795","id":"PMC_8702795","title":"SCO1 and SCO2 act as high copy suppressors of a mitochondrial copper recruitment defect in Saccharomyces cerevisiae.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8702795","citation_count":278,"is_preprint":false},{"pmid":"21563821","id":"PMC_21563821","title":"A targetable fluorescent sensor reveals that copper-deficient SCO1 and SCO2 patient cells prioritize mitochondrial copper homeostasis.","date":"2011","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/21563821","citation_count":210,"is_preprint":false},{"pmid":"15229189","id":"PMC_15229189","title":"Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15229189","citation_count":204,"is_preprint":false},{"pmid":"10749987","id":"PMC_10749987","title":"Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10749987","citation_count":194,"is_preprint":false},{"pmid":"17189203","id":"PMC_17189203","title":"The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis.","date":"2007","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17189203","citation_count":179,"is_preprint":false},{"pmid":"16091356","id":"PMC_16091356","title":"Human Sco1 and Sco2 function as copper-binding proteins.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16091356","citation_count":137,"is_preprint":false},{"pmid":"19336478","id":"PMC_19336478","title":"Human SCO2 is required for the synthesis of CO II and as a thiol-disulphide oxidoreductase for SCO1.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19336478","citation_count":135,"is_preprint":false},{"pmid":"11751685","id":"PMC_11751685","title":"Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11751685","citation_count":103,"is_preprint":false},{"pmid":"25525168","id":"PMC_25525168","title":"Detection of mutations in LRPAP1, CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2 in 298 families with early-onset high myopia by exome sequencing.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/25525168","citation_count":94,"is_preprint":false},{"pmid":"21820150","id":"PMC_21820150","title":"Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer.","date":"2011","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21820150","citation_count":90,"is_preprint":false},{"pmid":"23643385","id":"PMC_23643385","title":"Mutations in SCO2 are associated with autosomal-dominant high-grade myopia.","date":"2013","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23643385","citation_count":88,"is_preprint":false},{"pmid":"24403053","id":"PMC_24403053","title":"Human COX20 cooperates with SCO1 and SCO2 to mature COX2 and promote the assembly of cytochrome c oxidase.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24403053","citation_count":86,"is_preprint":false},{"pmid":"16083427","id":"PMC_16083427","title":"Tissue-specific cytochrome c oxidase assembly defects due to mutations in SCO2 and SURF1.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16083427","citation_count":83,"is_preprint":false},{"pmid":"25959673","id":"PMC_25959673","title":"Cooperation between COA6 and SCO2 in COX2 maturation during cytochrome c oxidase assembly links two mitochondrial cardiomyopathies.","date":"2015","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25959673","citation_count":74,"is_preprint":false},{"pmid":"12020273","id":"PMC_12020273","title":"Cytochrome c oxidase deficiency due to a novel SCO2 mutation mimics Werdnig-Hoffmann disease.","date":"2002","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12020273","citation_count":74,"is_preprint":false},{"pmid":"10854440","id":"PMC_10854440","title":"A human SCO2 mutation helps define the role of Sco1p in the cytochrome oxidase assembly pathway.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10854440","citation_count":73,"is_preprint":false},{"pmid":"11673586","id":"PMC_11673586","title":"Homozygosity (E140K) in SCO2 causes delayed infantile onset of cardiomyopathy and neuropathy.","date":"2001","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11673586","citation_count":68,"is_preprint":false},{"pmid":"19837698","id":"PMC_19837698","title":"Analysis of mouse models of cytochrome c oxidase deficiency owing to mutations in Sco2.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19837698","citation_count":64,"is_preprint":false},{"pmid":"11931660","id":"PMC_11931660","title":"Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11931660","citation_count":61,"is_preprint":false},{"pmid":"14970747","id":"PMC_14970747","title":"Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper?","date":"2004","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/14970747","citation_count":52,"is_preprint":false},{"pmid":"17850752","id":"PMC_17850752","title":"A structural characterization of human SCO2.","date":"2007","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/17850752","citation_count":49,"is_preprint":false},{"pmid":"29351582","id":"PMC_29351582","title":"SCO2 mutations cause early-onset axonal Charcot-Marie-Tooth disease associated with cellular copper deficiency.","date":"2018","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29351582","citation_count":48,"is_preprint":false},{"pmid":"14994243","id":"PMC_14994243","title":"Novel SCO2 mutation (G1521A) presenting as a spinal muscular atrophy type I phenotype.","date":"2004","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/14994243","citation_count":47,"is_preprint":false},{"pmid":"26309161","id":"PMC_26309161","title":"The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26309161","citation_count":45,"is_preprint":false},{"pmid":"26669719","id":"PMC_26669719","title":"Mitochondrial disease genes COA6, COX6B and SCO2 have overlapping roles in COX2 biogenesis.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26669719","citation_count":44,"is_preprint":false},{"pmid":"23319048","id":"PMC_23319048","title":"SCO2 induces p53-mediated apoptosis by Thr845 phosphorylation of ASK-1 and dissociation of the ASK-1-Trx complex.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23319048","citation_count":39,"is_preprint":false},{"pmid":"23612020","id":"PMC_23612020","title":"Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.","date":"2013","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23612020","citation_count":36,"is_preprint":false},{"pmid":"15499950","id":"PMC_15499950","title":"Clinical, biochemical and molecular analyses of six patients with isolated cytochrome c oxidase deficiency due to mutations in the SCO2 gene.","date":"2004","source":"Acta paediatrica (Oslo, Norway : 1992)","url":"https://pubmed.ncbi.nlm.nih.gov/15499950","citation_count":29,"is_preprint":false},{"pmid":"34369624","id":"PMC_34369624","title":"TCF19 and p53 regulate transcription of TIGAR and SCO2 in HCC for mitochondrial energy metabolism and stress adaptation.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/34369624","citation_count":28,"is_preprint":false},{"pmid":"21750704","id":"PMC_21750704","title":"Physical exercise regulates p53 activity targeting SCO2 and increases mitochondrial COX biogenesis in cardiac muscle with age.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21750704","citation_count":28,"is_preprint":false},{"pmid":"15210538","id":"PMC_15210538","title":"Association of mutations in SCO2, a cytochrome c oxidase assembly gene, with early fetal lethality.","date":"2004","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15210538","citation_count":28,"is_preprint":false},{"pmid":"23786650","id":"PMC_23786650","title":"Alpha particle-induced bystander effect is mediated by ROS via a p53-dependent SCO2 pathway in hepatoma cells.","date":"2013","source":"International journal of radiation biology","url":"https://pubmed.ncbi.nlm.nih.gov/23786650","citation_count":26,"is_preprint":false},{"pmid":"20159436","id":"PMC_20159436","title":"A novel mutation in the SCO2 gene in a neonate with early-onset cardioencephalomyopathy.","date":"2010","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20159436","citation_count":25,"is_preprint":false},{"pmid":"29193756","id":"PMC_29193756","title":"Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.","date":"2017","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29193756","citation_count":25,"is_preprint":false},{"pmid":"22515166","id":"PMC_22515166","title":"Copper and bezafibrate cooperate to rescue cytochrome c oxidase deficiency in cells of patients with SCO2 mutations.","date":"2012","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22515166","citation_count":25,"is_preprint":false},{"pmid":"19879173","id":"PMC_19879173","title":"A homozygous mutation in the SCO2 gene causes a spinal muscular atrophy like presentation with stridor and respiratory insufficiency.","date":"2009","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/19879173","citation_count":24,"is_preprint":false},{"pmid":"14972329","id":"PMC_14972329","title":"Human recombinant mutated forms of the mitochondrial COX assembly Sco2 protein differ from wild-type in physical state and copper binding capacity.","date":"2004","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/14972329","citation_count":22,"is_preprint":false},{"pmid":"20193760","id":"PMC_20193760","title":"Intracellular delivery of full length recombinant human mitochondrial L-Sco2 protein into the mitochondria of permanent cell lines and SCO2 deficient patient's primary cells.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20193760","citation_count":21,"is_preprint":false},{"pmid":"27499152","id":"PMC_27499152","title":"Distinctive interrelation of p53 with SCO2, COX, and TIGAR in human gastric cancer.","date":"2016","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/27499152","citation_count":21,"is_preprint":false},{"pmid":"18924171","id":"PMC_18924171","title":"Phenotypic consequences of a novel SCO2 gene mutation.","date":"2008","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/18924171","citation_count":20,"is_preprint":false},{"pmid":"16765077","id":"PMC_16765077","title":"A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathy.","date":"2006","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16765077","citation_count":20,"is_preprint":false},{"pmid":"19353847","id":"PMC_19353847","title":"A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile cardioencephalomyopathy.","date":"2009","source":"Clinical neuropathology","url":"https://pubmed.ncbi.nlm.nih.gov/19353847","citation_count":20,"is_preprint":false},{"pmid":"23719228","id":"PMC_23719228","title":"The natural history of SCO2 deficiency in 36 Polish children confirmed the genotype-phenotype correlation.","date":"2013","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/23719228","citation_count":18,"is_preprint":false},{"pmid":"17187620","id":"PMC_17187620","title":"Identification of a novel compound heterozygote SCO2 mutation in cytochrome c oxidase deficient fatal infantile cardioencephalomyopathy.","date":"2007","source":"Acta paediatrica (Oslo, Norway : 1992)","url":"https://pubmed.ncbi.nlm.nih.gov/17187620","citation_count":16,"is_preprint":false},{"pmid":"18254779","id":"PMC_18254779","title":"Structural analysis of tissues affected by cytochrome C oxidase deficiency due to mutations in the SCO2 gene.","date":"2008","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/18254779","citation_count":15,"is_preprint":false},{"pmid":"27052445","id":"PMC_27052445","title":"Association between SCO2 mutation and extreme myopia in Japanese patients.","date":"2016","source":"Japanese journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/27052445","citation_count":14,"is_preprint":false},{"pmid":"22792142","id":"PMC_22792142","title":"Association of high myopia with crystallin beta A4 (CRYBA4) gene polymorphisms in the linkage-identified MYP6 locus.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22792142","citation_count":14,"is_preprint":false},{"pmid":"20864674","id":"PMC_20864674","title":"Unexpected vascular enrichment of SCO1 over SCO2 in mammalian tissues: implications for human mitochondrial disease.","date":"2010","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20864674","citation_count":14,"is_preprint":false},{"pmid":"28428045","id":"PMC_28428045","title":"Sco2 deficient mice develop increased adiposity and insulin resistance.","date":"2017","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28428045","citation_count":13,"is_preprint":false},{"pmid":"34702781","id":"PMC_34702781","title":"Loss of Functional SCO2 Attenuates Oxidative Stress in Diabetic Kidney Disease.","date":"2021","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/34702781","citation_count":13,"is_preprint":false},{"pmid":"23407777","id":"PMC_23407777","title":"Mitochondrial cardioencephalomyopathy due to a novel SCO2 mutation in a Brazilian patient: case report and literature review.","date":"2013","source":"JAMA neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23407777","citation_count":12,"is_preprint":false},{"pmid":"23838601","id":"PMC_23838601","title":"Large copy number variations in combination with point mutations in the TYMP and SCO2 genes found in two patients with mitochondrial disorders.","date":"2013","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23838601","citation_count":12,"is_preprint":false},{"pmid":"26700591","id":"PMC_26700591","title":"Upregulation of energy metabolism-related, p53-target TIGAR and SCO2 in HuH-7 cells with p53 mutation by geranylgeranoic acid treatment.","date":"2015","source":"Biomedical research (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/26700591","citation_count":11,"is_preprint":false},{"pmid":"33318931","id":"PMC_33318931","title":"In vivo biodistribution study of TAT-L-Sco2 fusion protein, developed as protein therapeutic for mitochondrial disorders attributed to SCO2 mutations.","date":"2020","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/33318931","citation_count":10,"is_preprint":false},{"pmid":"35002215","id":"PMC_35002215","title":"Mutational screening of AGRN, SLC39A5, SCO2, P4HA2, BSG, ZNF644, and CPSF1 in a Chinese cohort of 103 patients with nonsyndromic high myopia.","date":"2021","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/35002215","citation_count":8,"is_preprint":false},{"pmid":"34962434","id":"PMC_34962434","title":"Expression of SCO1 and SCO2 after form-deprivation myopia in Guinea pigs.","date":"2021","source":"European journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/34962434","citation_count":7,"is_preprint":false},{"pmid":"23364397","id":"PMC_23364397","title":"Exome sequencing reveals SCO2 mutations in a family presented with fatal infantile hyperthermia.","date":"2013","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23364397","citation_count":7,"is_preprint":false},{"pmid":"26427993","id":"PMC_26427993","title":"No Evidence for Association of SCO2 Heterozygosity with High-Grade Myopia or Other Diseases with Possible Mitochondrial Dysfunction.","date":"2015","source":"JIMD reports","url":"https://pubmed.ncbi.nlm.nih.gov/26427993","citation_count":7,"is_preprint":false},{"pmid":"36678915","id":"PMC_36678915","title":"Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency.","date":"2023","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/36678915","citation_count":6,"is_preprint":false},{"pmid":"34957485","id":"PMC_34957485","title":"Loss of Functional SCO2 Attenuates Oxidative Stress in Diabetic Kidney Disease.","date":"2021","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/34957485","citation_count":6,"is_preprint":false},{"pmid":"24726617","id":"PMC_24726617","title":"Imatinib inhibits the expression of SCO2 and FRATAXIN genes that encode mitochondrial proteins in human Bcr-Abl⁺ leukemia cells.","date":"2014","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24726617","citation_count":5,"is_preprint":false},{"pmid":"19353431","id":"PMC_19353431","title":"Remodelling of skeletal muscle cells in children with SCO2 gene mutation - ultrastructural study.","date":"2009","source":"Folia neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/19353431","citation_count":3,"is_preprint":false},{"pmid":"25097374","id":"PMC_25097374","title":"Analysis of reported SCO2 gene mutations affecting cytochrome c oxidase activity in various diseases.","date":"2014","source":"Bioinformation","url":"https://pubmed.ncbi.nlm.nih.gov/25097374","citation_count":3,"is_preprint":false},{"pmid":"41683819","id":"PMC_41683819","title":"Bulk and Single-Cell Transcriptomics Reveal That SCO2 Drives Psoriasis via Activating CCR7+ Dendritic Cell.","date":"2026","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41683819","citation_count":1,"is_preprint":false},{"pmid":"41925776","id":"PMC_41925776","title":"Coal Dust Nanoparticles Induce Colitis-Like Lesions in Rats via Gut Microbiota Dysbiosis and P53/SCO2/SLC7A11-Mediated Epithelial Ferroptosis.","date":"2026","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41925776","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":34607,"output_tokens":5616,"usd":0.094031,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14365,"output_tokens":4608,"usd":0.093512,"stage2_stop_reason":"end_turn"},"total_usd":0.187543,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Mutations in human SCO2 cause fatal infantile cardioencephalomyopathy with COX deficiency; immunohistochemical studies showed the enzymatic deficiency was due to loss of mtDNA-encoded COX subunits (COX I–III), most severely in cardiac and skeletal muscle, establishing SCO2 as a COX assembly factor.\",\n      \"method\": \"Patient mutation identification, immunohistochemistry of COX subunits in patient tissues\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — foundational disease-gene paper with multiple patients, direct immunohistochemical localization of defect, independently replicated in many subsequent studies\",\n      \"pmids\": [\"10545952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Yeast SCO2 (Sco2p) is a mitochondrial membrane-localized protein that, when overexpressed, can partially suppress respiratory defects caused by absence of the copper recruitment factor Cox17p, but cannot suppress loss of Sco1p, indicating Sco1p and Sco2p have overlapping but non-identical functions in mitochondrial copper delivery to cytochrome oxidase.\",\n      \"method\": \"Multicopy suppressor screen in Saccharomyces cerevisiae, respiratory growth assays, genetic epistasis with cox17 and sco1 null mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple mutant combinations, replicated conceptually across many subsequent studies\",\n      \"pmids\": [\"8702795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Human SCO1 and SCO2 have non-overlapping, cooperative functions in mitochondrial copper delivery to COX. Overexpression of COX17 rescued COX deficiency in SCO2 but not SCO1 patient cells. Overexpression of either SCO protein in the reciprocal patient background produced a dominant-negative phenotype, suggesting physical interaction. Size exclusion chromatography indicated both proteins function as homodimers. A model was proposed in which COX17 delivers copper to SCO2, which transfers it to the CuA site, a reaction facilitated by SCO1.\",\n      \"method\": \"Immunoblot analysis, overexpression rescue experiments in patient cell lines, chimeric protein complementation, size exclusion chromatography\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (rescue, dominant-negative, chromatography) in a single rigorous study with patient cell lines\",\n      \"pmids\": [\"15229189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Human Sco1 and Sco2 bind copper ions; both can bind Cu(I) (trigonal geometry) and Cu(II) (type II site). The two conserved cysteines and a histidyl residue critical for copper binding in yeast Sco1 are also critical for in vivo function of human Sco1 and Sco2. Asp238 in human Sco1 (conserved in yeast) is required for Cu(II) binding and normal function; its mutation abrogates the Cu(II) visible transitions and renders the protein nonfunctional.\",\n      \"method\": \"Expression of soluble domains in bacteria and yeast cytoplasm, X-ray absorption spectroscopy (EXAFS/XANES), site-directed mutagenesis, in vivo yeast complementation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro copper-binding characterization combined with mutagenesis and in vivo functional assays, multiple orthogonal spectroscopic methods\",\n      \"pmids\": [\"16091356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Human SCO1 and SCO2 have additional roles in cellular copper homeostasis beyond COX assembly. Mutations in either SCO cause cellular copper deficiency that is tissue- and allele-specific and dissociable from COX assembly defects. This phenotype reflects increased copper efflux rather than reduced uptake, and can be suppressed by overexpression of SCO2 but not SCO1, suggesting a mitochondrial pathway for regulating cellular copper content that signals through SCO1 and SCO2.\",\n      \"method\": \"Patient cell line analysis, shRNA knockdown, copper efflux/uptake measurements, overexpression rescue experiments\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (RNAi, overexpression, copper flux assays) in patient and control cells, single lab\",\n      \"pmids\": [\"17189203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NMR structure of the soluble domain of human Sco2 was determined in apo and Cu(I)-loaded forms. The structural and metal-binding features of Cu(I)Sco2 are similar to Sco1, but the dynamic properties and conformational disorder of the apo forms differ substantially between Sco1 and Sco2, accounting for their different physicochemical properties. Known pathogenic mutations were mapped onto this structure.\",\n      \"method\": \"NMR spectroscopy (structure determination and dynamics), copper(I) binding characterization\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — atomic resolution NMR structure with functional (dynamics) validation, single lab\",\n      \"pmids\": [\"17850752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SCO2 acts upstream of SCO1 in COX II (CO II) biogenesis and is indispensable for CO II synthesis. Pulse-labeling showed CO II synthesis is reduced in SCO2, but not SCO1, patient cells. SCO2 also acts as a thiol-disulphide oxidoreductase to oxidize the copper-coordinating cysteines in SCO1 during CO II maturation; perturbation of the ratio of oxidized to reduced cysteines in SCO1 occurs in both SCO backgrounds and is corrected by SCO2 modulation.\",\n      \"method\": \"Mitochondrial translation pulse-labeling, RNAi knockdown, thiol-trapping/redox state analysis of SCO1 cysteines, patient cell lines\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (pulse-labeling, RNAi, redox state assay) establishing epistatic order and enzymatic function, replicated conceptually across labs\",\n      \"pmids\": [\"19336478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In a yeast model, the S240F mutation in Sco1p (corresponding to a human SCO2 pathogenic mutation) allows partial but incorrect assembly of cytochrome oxidase with altered cytochrome aa3 spectrum and a specific absence of subunit 2 from the assembled complex, indicating Sco1p (and by orthology SCO2) provides copper to the CuA site on subunit 2 at a late step in the assembly pathway.\",\n      \"method\": \"Yeast site-directed mutagenesis, respiratory growth assays, spectrophotometric cytochrome analysis, immunoblot of COX subunits\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean yeast model with mutagenesis and biochemical characterization, ortholog study rather than direct human SCO2 experiment\",\n      \"pmids\": [\"10854440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Recombinant human Sco2 protein binds copper with 1:1 stoichiometry and forms homomeric complexes in vitro independent of the CxxxC metal-binding motif. In patient myoblasts, COX activity was completely rescued by retroviral SCO2 gene transduction, and also by copper-histidine supplementation (300 µM) to culture medium, establishing that exogenous copper can bypass Sco2 function.\",\n      \"method\": \"Recombinant protein production and copper-binding assay, retroviral gene complementation in patient myoblasts, copper supplementation rescue assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro copper binding plus cell-based complementation, single lab\",\n      \"pmids\": [\"11751685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"COX deficiency in SCO2-mutant fibroblasts, myoblasts, and myotubes can be restored to near-normal levels by addition of CuCl2 to culture medium, confirming that the primary defect is in copper delivery to COX.\",\n      \"method\": \"Copper supplementation in cultured patient cells, spectrophotometric COX activity assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell types tested, consistent with copper-delivery function, single lab\",\n      \"pmids\": [\"11931660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mutant Sco2 proteins (E140K and S225F) differ from wild-type in physical conformation (circular dichroism, thermal denaturation) and copper-binding capacity: E140K binds markedly less copper and forms a non-reducible dimer (vs. monomer for wild-type), while S225F binds more copper than wild-type. These data show pathogenic mutations alter protein conformation and disrupt normal copper transport.\",\n      \"method\": \"Recombinant protein production, circular dichroism spectroscopy, thermal denaturation, copper-binding assays, gel electrophoresis\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical and biophysical characterization with multiple methods, single lab\",\n      \"pmids\": [\"14972329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In SCO2 patient tissues (heart, skeletal muscle, brain), COX assembly intermediates accumulate including a COX1·COX4·COX5A subcomplex and free COX4·COX5A subcomplex, with virtual absence of free COX2, indicating that absence of the CuA centre reduces COX2 stability and that association of COX4 and COX5A precedes their addition to COX1. Liver in SCO2 patients contained normal holoenzyme levels despite reduced SCO2 protein.\",\n      \"method\": \"Blue native PAGE of patient tissues, immunoblot of COX subunits and subcomplexes, analysis across multiple tissues\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct analysis of assembly intermediates in multiple patient tissues, defines pathway order, single lab\",\n      \"pmids\": [\"16083427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SCO2 is required for COX assembly in vivo; homozygous Sco2 knockout mice are embryonic lethal. Compound heterozygous knock-in/knockout mice (KI/KO, expressing E129K corresponding to human E140K) are viable but show muscle weakness, respiratory chain deficiencies, COX assembly defects, and reduced mitochondrial copper content in multiple tissues, without reduction in total tissue copper.\",\n      \"method\": \"Mouse knockout and knock-in model generation, respiratory chain enzyme assays, COX assembly analysis, copper content measurement (ICP-MS)\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mouse model with multiple biochemical readouts, establishes essential function in vivo\",\n      \"pmids\": [\"19837698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Using the mitochondria-targeted copper sensor Mito-CS1, total copper and exchangeable mitochondrial Cu(+) pools in SCO1 and SCO2 patient fibroblasts are largely unaltered relative to wild-type controls despite global cellular copper deficiency, demonstrating that cells prioritize mitochondrial copper homeostasis even when SCO metallochaperones are defective.\",\n      \"method\": \"Targetable fluorescent copper sensor (Mito-CS1) live-cell imaging, biochemical copper measurements in patient fibroblasts\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel chemical tool with biochemical validation, single lab, patient fibroblasts\",\n      \"pmids\": [\"21563821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SCO1 localizes predominantly to blood vessels (endothelium) in mouse and human tissues, whereas SCO2 is barely detectable in this tissue; conversely, SCO1 expression is very high in liver while SCO2 is high in muscle. This differential tissue distribution provides a mechanistic basis for the distinct tissue-specific COX deficiencies and different clinical phenotypes associated with SCO1 vs. SCO2 mutations.\",\n      \"method\": \"Immunofluorescence and immunohistochemistry of mouse and human tissue sections, tissue fractionation\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by IHC/IF across multiple tissues in two species, functional inference drawn from differential expression patterns\",\n      \"pmids\": [\"20864674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"COX20 acts as an early chaperone that stabilizes newly synthesized COX2 and presents it to the SCO1/SCO2 metallochaperone module. Immunoprecipitation showed COX20 interacts with newly synthesized COX2, and SCO1 and SCO2 act on COX20-bound COX2. Loss of COX20 generates COX1·COX4-containing subassemblies similar to those in SCO1/SCO2 patient fibroblasts, establishing the pathway order: COX20 → COX2 stabilization → SCO1/SCO2 maturation.\",\n      \"method\": \"siRNA knockdown, TALEN knockout cell lines, mitochondrial translation pulse-labeling, co-immunoprecipitation with COX20-FLAG, blue native PAGE\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal genetic and biochemical approaches, co-IP establishes physical interaction, pathway order confirmed by matching assembly intermediates\",\n      \"pmids\": [\"24403053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"COA6 interacts transiently with the copper-containing catalytic domain of newly synthesized COX2, and COA6 and SCO2 physically interact; pathogenic mutations in either protein disrupt the COA6-SCO2 complex. Genetic epistasis in yeast showed that simultaneous deletion of Coa6 and Sco2 completely abrogates Cox2 biogenesis, and overexpression of Sco proteins partially rescues the coa6Δ phenotype, placing COA6 in the SCO2-containing copper relay system for COX2 metallation.\",\n      \"method\": \"Co-immunoprecipitation, pulse-labeling, yeast genetic epistasis (double deletion), overexpression rescue, biochemical interaction studies\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, genetic epistasis across species, pulse-labeling, multiple orthogonal methods\",\n      \"pmids\": [\"25959673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In yeast, simultaneous deletion of Coa6 and Sco2 completely abrogates Cox2 biogenesis, and copper supplementation fails to rescue Cox2 levels in these double mutants (unlike coa6Δ single mutants). Physical interactions between Coa6, Cox2, Cox12, and Sco proteins were demonstrated biochemically, placing COA6/SCO2 in the same copper delivery pathway to Cox2.\",\n      \"method\": \"Yeast genetic epistasis (comprehensive double deletions), biochemical co-precipitation, western blot, copper supplementation rescue assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — comprehensive epistasis plus physical interaction studies, independent corroboration of COA6-SCO2 pathway from two labs (PMID 25959673 and 26669719)\",\n      \"pmids\": [\"26669719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SCO2 induces apoptosis by increasing ROS generation, which causes dissociation of the ASK-1/thioredoxin (Trx) inhibitory complex and phosphorylation of ASK-1 at Thr845, activating downstream JNK/p38 apoptotic cascades in tumor xenografts. This establishes an apoptotic function for SCO2 via the ROS-ASK-1 kinase pathway downstream of p53.\",\n      \"method\": \"Tumor xenograft model, ROS measurement, co-immunoprecipitation (ASK-1/Trx), kinase phosphorylation assays, exogenous SCO2 gene addition\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical assays and in vivo xenograft validation, single lab\",\n      \"pmids\": [\"23319048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Recombinant full-length TAT-L-Sco2 fusion protein can be transduced into mitochondria of human cell lines and processed to the mature Sco2 protein; transduction into SCO2/COX-deficient patient fibroblasts led to partial recovery of COX activity, demonstrating that exogenous delivery of functional Sco2 protein to mitochondria is sufficient to restore enzymatic activity.\",\n      \"method\": \"Protein transduction domain (PTD/TAT) technology, subcellular fractionation, cell-free translation/import assay with 35S-labeling, COX activity assay in patient fibroblasts\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct mitochondrial import demonstrated by radiolabeling and fractionation, functional rescue in patient cells, single lab\",\n      \"pmids\": [\"20193760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SCO2 patient fibroblasts with compound heterozygous mutations near the conserved CxxxC copper-binding motif show reduced SCO2 protein levels, decreased cellular copper levels, and COX deficiency, establishing that SCO2 mutations cause cellular copper deficiency as part of the pathogenic mechanism in axonal Charcot-Marie-Tooth disease.\",\n      \"method\": \"Patient fibroblast analysis, immunoblot, copper content measurement, COX activity assay\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient cell biochemical analysis, single lab, extends copper-deficiency mechanism to a new disease context\",\n      \"pmids\": [\"29351582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"COX deficiency in SCO2 patient fibroblasts can be rescued by transfer of chromosome 22 (which carries SCO2) but not other chromosomes, confirming SCO2 is the causative gene. The COX deficiency (~50%) in patient fibroblasts did not result in a decrease in steady-state levels of COX subunit polypeptides, suggesting a functional rather than structural assembly defect.\",\n      \"method\": \"Chromosome transfer rescue experiment (microcell-mediated chromosome transfer), COX enzyme activity assay, immunoblot of COX subunits\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chromosome transfer rescue establishes causality, single lab\",\n      \"pmids\": [\"10749987\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SCO2 is a mitochondrial inner membrane metallochaperone that functions in two key roles: (1) it acts upstream of SCO1 in COX2 (COXII) biogenesis by being required for COX2 synthesis and by acting as a thiol-disulfide oxidoreductase that oxidizes the copper-coordinating cysteines in SCO1, enabling CuA site maturation of COX2 within a COX20→COX2→(SCO2/SCO1) assembly pathway that also involves COA6; and (2) together with SCO1, it participates in a mitochondrial signaling pathway that regulates cellular copper homeostasis by controlling copper efflux, explaining tissue-specific COX deficiencies and broader copper metabolism phenotypes caused by SCO2 mutations.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SCO2 is a mitochondrial copper metallochaperone required for the biogenesis of cytochrome c oxidase (COX), where its loss produces severe, tissue-specific COX deficiency underlying fatal infantile cardioencephalomyopathy [#0, #21]. SCO2 binds copper in both Cu(I) and Cu(II) states through conserved CxxxC cysteines and a critical histidine, and adopts a thioredoxin-like fold whose apo-form dynamics distinguish it from its paralog SCO1 [#3, #5]. Within COX2 maturation, SCO2 acts upstream of SCO1: it is indispensable for COX2 synthesis and functions as a thiol-disulfide oxidoreductase that oxidizes the copper-coordinating cysteines of SCO1, enabling delivery of copper to the CuA site of COX2 [#6, #7]. This metallation occurs within an ordered assembly pathway in which COX20 stabilizes newly synthesized COX2 and presents it to the SCO1/SCO2 module, with COA6 acting in the same copper relay and physically engaging SCO2 [#15, #16, #17]; loss of the CuA centre destabilizes COX2 and arrests assembly at COX1-COX4-COX5A subcomplexes [#11]. SCO2 also participates with SCO1 in a mitochondrial signaling pathway that governs whole-cell copper homeostasis by controlling copper efflux, such that SCO2 mutations cause dissociable cellular copper deficiency distinct from the COX defect [#4]. Consistent with a copper-delivery function, COX activity in SCO2-mutant patient cells is restored by copper supplementation [#9], and SCO2 is essential in vivo, with knockout embryonic lethality and copper-dependent respiratory phenotypes in mouse models [#12]. Beyond COX assembly, SCO2 has been linked to a p53-downstream apoptotic function via ROS-mediated ASK-1 activation [#18] and to axonal Charcot-Marie-Tooth disease through copper-deficiency mechanisms [#20].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that the SCO gene products act in mitochondrial copper delivery to cytochrome oxidase, distinguishing SCO2 from the related copper factors SCO1 and COX17.\",\n      \"evidence\": \"Multicopy suppressor screen and genetic epistasis with cox17 and sco1 nulls in yeast\",\n      \"pmids\": [\"8702795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the human SCO2 biochemical activity\", \"Overlapping vs. distinct roles of Sco1p and Sco2p left unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified SCO2 as a human disease gene and a COX assembly factor, explaining a fatal infantile cardioencephalomyopathy through loss of mtDNA-encoded COX subunits.\",\n      \"evidence\": \"Patient mutation identification and immunohistochemistry of COX subunits in patient tissues\",\n      \"pmids\": [\"10545952\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular function of SCO2 in assembly not yet defined\", \"Basis of tissue specificity unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Confirmed SCO2 causality by complementation and showed the defect is functional rather than structural, while ortholog modeling placed Sco activity at a late CuA-metallation step on COX2.\",\n      \"evidence\": \"Microcell-mediated chromosome 22 transfer rescue in patient fibroblasts; yeast S240F mutagenesis with spectrophotometric COX analysis\",\n      \"pmids\": [\"10749987\", \"10854440\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct human SCO2 enzymatic role not yet shown\", \"How copper reaches CuA mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrated that recombinant human Sco2 binds copper and that exogenous copper or SCO2 gene transfer rescues COX in patient cells, framing SCO2 as a copper-delivery protein.\",\n      \"evidence\": \"Recombinant copper-binding assay, retroviral complementation and copper-histidine supplementation in patient myoblasts\",\n      \"pmids\": [\"11751685\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry and copper-binding site not yet structurally defined\", \"Single-lab cell-based rescue\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Generalized the copper-delivery defect across multiple SCO2-mutant cell types by showing CuCl2 rescues COX activity.\",\n      \"evidence\": \"Copper supplementation and spectrophotometric COX assays in patient fibroblasts, myoblasts, myotubes\",\n      \"pmids\": [\"11931660\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not separate intramitochondrial from systemic copper effects\", \"Single lab\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed SCO1 and SCO2 have non-overlapping cooperative roles and likely interact physically, and that pathogenic mutations alter conformation and copper binding.\",\n      \"evidence\": \"Overexpression rescue and dominant-negative complementation in patient cells, size-exclusion chromatography; recombinant CD/thermal denaturation and copper-binding of E140K and S225F mutants\",\n      \"pmids\": [\"15229189\", \"14972329\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical SCO1-SCO2 interaction inferred, not co-purified\", \"Mechanism of dominant-negative effect unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the copper-binding chemistry and the residues essential for SCO function, and resolved the COX2 assembly intermediates that accumulate without the CuA centre.\",\n      \"evidence\": \"EXAFS/XANES and site-directed mutagenesis with yeast complementation; blue native PAGE of patient tissues\",\n      \"pmids\": [\"16091356\", \"16083427\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic mechanism of copper transfer not yet defined\", \"Basis for liver sparing unexplained\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealed a COX-independent role for SCO2 in cellular copper homeostasis acting through control of copper efflux, and that SCO2 (not SCO1) overexpression suppresses the copper-deficiency phenotype.\",\n      \"evidence\": \"Patient cells, shRNA knockdown, copper efflux/uptake assays and overexpression rescue; NMR structure of Cu(I)/apo Sco2 soluble domain\",\n      \"pmids\": [\"17189203\", \"17850752\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling intermediates linking mitochondrial SCO status to efflux unknown\", \"Structural difference vs. SCO1 not linked to distinct catalysis\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established the epistatic order and enzymatic activity: SCO2 acts upstream of SCO1 and oxidizes SCO1's copper-coordinating cysteines as a thiol-disulfide oxidoreductase during COX2 maturation.\",\n      \"evidence\": \"Mitochondrial translation pulse-labeling, RNAi, and thiol-trapping redox-state analysis in patient cells\",\n      \"pmids\": [\"19336478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct redox enzymology not reconstituted in vitro\", \"Source of oxidizing equivalents for SCO2 unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated SCO2 is essential in vivo and that tissue-specific paralog expression and exogenous protein delivery account for and can correct the disease phenotype.\",\n      \"evidence\": \"Sco2 knockout/knock-in mouse models with ICP-MS copper measurement; IHC/IF tissue distribution of SCO1 vs SCO2; TAT-Sco2 protein transduction into patient fibroblasts\",\n      \"pmids\": [\"19837698\", \"20864674\", \"20193760\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of mitochondrial copper reduction without total tissue copper change unresolved\", \"Therapeutic transduction only partially restored activity\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed cells prioritize mitochondrial copper pools even when SCO chaperones are defective, refining where the copper-homeostasis defect manifests.\",\n      \"evidence\": \"Mito-CS1 fluorescent copper sensor imaging and biochemical copper measurement in patient fibroblasts\",\n      \"pmids\": [\"21563821\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cytosolic copper-deficiency mechanism not directly imaged\", \"Single lab, single tool\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified a non-assembly, p53-downstream apoptotic role for SCO2 via ROS-driven ASK-1 activation.\",\n      \"evidence\": \"Tumor xenografts, ROS measurement, ASK-1/Trx co-IP and kinase phosphorylation assays with exogenous SCO2\",\n      \"pmids\": [\"23319048\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Link between SCO2 copper/COX function and ROS generation not mechanistically connected\", \"Single-lab finding in tumor context\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Placed SCO2 within an ordered assembly line by identifying COX20 as the upstream chaperone that stabilizes COX2 and presents it to the SCO1/SCO2 module.\",\n      \"evidence\": \"siRNA/TALEN knockout, pulse-labeling, COX20-FLAG co-IP and blue native PAGE\",\n      \"pmids\": [\"24403053\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct handoff mechanism from COX20 to SCO2 not resolved\", \"Whether SCO2 binds COX20-COX2 directly not shown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Integrated COA6 into the SCO2 copper relay through physical interaction and cross-species epistasis, defining a metallation module for COX2.\",\n      \"evidence\": \"Reciprocal co-IP, pulse-labeling, yeast double-deletion epistasis and copper-supplementation rescue across two independent studies\",\n      \"pmids\": [\"25959673\", \"26669719\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of copper transfer among COA6, SCO2, SCO1 not fully resolved\", \"Whether COA6 is a copper carrier or stabilizer undetermined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended the SCO2 copper-deficiency mechanism to a new disease, axonal Charcot-Marie-Tooth disease, linking CxxxC-proximal mutations to reduced cellular copper and COX deficiency.\",\n      \"evidence\": \"Patient fibroblast immunoblot, copper content and COX activity assays\",\n      \"pmids\": [\"29351582\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Neuron-specific pathogenic mechanism not directly tested\", \"Single-lab patient analysis\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the mitochondrial SCO1/SCO2 status is transduced into a cytosolic copper-efflux signal, and how SCO2's redox/copper-transfer chemistry is reconstituted in vitro, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No identified signaling intermediate linking SCO status to copper exporters\", \"No in vitro reconstitution of SCO2-catalyzed CuA metallation\", \"Mechanistic link between SCO2 and ROS/apoptosis pathway unestablished\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [3, 5, 8]},\n      {\"term_id\": \"GO:0046872\", \"supporting_discovery_ids\": [3, 5, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [1, 12, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 6, 15]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [4, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SCO1\",\n      \"COX20\",\n      \"COA6\",\n      \"COX2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}